SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006266
Filing Date
2021-05-06
Accepted
2021-05-06 16:39:03
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20210331x10q.htm 10-Q 849216
2 EX-31.1 nxtc-20210331ex3115dcb26.htm EX-31.1 12902
3 EX-31.2 nxtc-20210331ex3124a8a29.htm EX-31.2 12698
4 EX-32.1 nxtc-20210331ex3216bda16.htm EX-32.1 12240
  Complete submission text file 0001558370-21-006266.txt   4104888

Data Files

Seq Description Document Type Size
5 EX-101.INS nxtc-20210331.xml EX-101.INS 972376
6 EX-101.SCH nxtc-20210331.xsd EX-101.SCH 24882
7 EX-101.CAL nxtc-20210331_cal.xml EX-101.CAL 37616
8 EX-101.DEF nxtc-20210331_def.xml EX-101.DEF 77772
9 EX-101.LAB nxtc-20210331_lab.xml EX-101.LAB 288898
10 EX-101.PRE nxtc-20210331_pre.xml EX-101.PRE 188515
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 21898511
SIC: 2834 Pharmaceutical Preparations